March 20 (Reuters) - Roche Holding AG ROPC.S:
ROCHE SPOKESPERSON: DECIDED TO STOP CLINICAL DEVELOPMENT OF EMUGROBART FOR BOTH SPINAL MUSCULAR ATROPHY & FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
ROCHE SPOKESPERSON: PHASE II DEVELOPMENT OF EMUGROBART IN OBESITY CONTINUES AS PLANNED
Source text: [ID:]